Cirius Therapeutics is a biopharmaceutical company based in San Diego, CA, specializing in the development of innovative treatments for NASH (nonalcoholic steatohepatitis). Their dedicated team of experts is committed to advancing scientific research and publishing cutting-edge findings in the field.
With a focus on NASH, Cirius Therapeutics aims to address the unmet medical needs of patients through their advanced scientific approach. Their board of directors oversees strategic decision-making to drive the company's mission forward.
Generated from the website